Evaluating Liver Function in Breast Cancer Patients
Author Information
Author(s): I. Virgolini, G. Kornek, J. Hobart, S.R. Li, M. Raolerer, H. Bergmann, W. Scheithauer, Totiu Pantev, P. Angelberger, H. Sinzinger, R. Höfer
Primary Institution: University of Vienna
Hypothesis
Can 99mTc-galactosyl neoglycoalbumin (99mTc-NGA) effectively assess liver function in patients with advanced breast cancer?
Conclusion
The study found that 99mTc-NGA imaging can provide valuable insights into liver function and morphology in breast cancer patients.
Supporting Evidence
- Patients with liver metastases showed significantly lower hepatic binding protein concentrations.
- 99mTc-NGA imaging revealed cold spots in areas of liver metastases.
- Chemotherapy with amonafide increased hepatic binding protein concentrations in some patients.
Takeaway
Doctors used a special scan to see how well the liver is working in women with breast cancer, and they found it can help tell if the liver is healthy or not.
Methodology
The study involved scintigraphic studies using 99mTc-NGA to assess liver function and morphology in breast cancer patients.
Limitations
The study had a small sample size and focused only on women with advanced breast cancer.
Participant Demographics
All participants were women with histologically documented advanced breast cancer.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website